Akers Biosciences Inc.
Period Ending Dec 31, 2013 Dec 31, 2012
Total Revenue 3,578 1,564
Cost of Revenue 1,914 1,008
Gross Profit 1,664 556
Operating Expenses
Research and Development 1,007 900
Sales, General and Admin. 2,209 2,132
Non-Recurring Items - -
Other 259 259
Operating Income (1,811) (2,735)
Income From Continuing Operations
Add'l Income/Expense Items 284 10
Earnings Before Interest and Tax (1,527) (2,725)
Interest Expense - -
Earnings Before Tax (1,527) (2,725)
Income Tax - (167)
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (1,527) (2,558)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (1,527) (2,558)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (1,527) (2,558)